secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0000950170-23-025787
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

RxSight shareholders re-elect three Class II directors, approve charter amendment, ratify auditor
--------------------------------------------------------------------------------

- Re-elected William J. Link, Robert Warner, and Shweta Singh Maniar as Class II directors with 24.2M, 21.9M, and 21.2M votes for, respectively.
- Approved certificate of incorporation amendment for officer exculpation under Delaware law: 22.2M for, 2.2M against.
- Ratified Ernst & Young as independent auditor for FY2023: 29.5M for, 3,150 against.
- 87.2% of outstanding shares (29.6M of 33.97M) represented at the June 1, 2023 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/0000950170-23-025787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/rxst-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-025787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer